12 April 2023
Latham Advises on Ardian and NB Renaissance’s Acquisition of Majority Stake in Neopharmed Gentili
Advising firms
Deal team
10 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Marcello Bragliani Lead | Latham & Watkins LLP | Partner | Not stated | Milan |
| Antongiulio Scialpi Lead | Latham & Watkins LLP | Partner | Not stated | Milan |
| Jeff Lawlis Lead | Latham & Watkins LLP | Partner | Not stated | Milan |
| Fergus O'Domhnaill Lead | Latham & Watkins LLP | Partner | Not stated | London |
| Davide Camasi | Latham & Watkins LLP | Associate | Not stated | Milan |
| Pasquale Spiezio | Latham & Watkins LLP | Associate | Not stated | Milan |
| Julie Van der Meersche | Latham & Watkins LLP | Associate | Not stated | London |
| Chloe Gontier | Latham & Watkins LLP | Associate | Not stated | London |
| Philip Rigley | Latham & Watkins LLP | Associate | Not stated | London |
| Blanca Vazquez de Castro | Latham & Watkins LLP | Associate | Not stated | Madrid |
7 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- EUR 700m (approximately €700 million)
- What the figure measures
- Facility amount
- Client
- a club of direct lendersLenders
- Counterparties
- Ardian (Investor)
NB Renaissance (Investor)
Neopharmed Gentili S.p.A. (Target)